ReviewCancers2021
The Impact of the COVID-19 Pandemic on Oncology Care and Clinical Trials.
Review in Cancers, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
25 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- COVID-19's disruptions to cancer care pathways and widening of health inequalities in the UK: a systematic review.BMC health services research · 2026Pooled it
- The impact of the COVID-19 pandemic on time to treatment in head and neck cancer management: a systematic review.Acta oncologica (Stockholm, Sweden) · 2025Pooled it
- Trial
- Learning from an Emerging Infection: How the COVID-19 Pandemic Reshaped Gastric Cancer Care.Life (Basel, Switzerland) · 2026Review
- Article
- Review
- COVID-19 Pandemic Impact on Delays in Diagnosis and Treatment for Cervical Cancer in Montreal, Canada.Current oncology (Toronto, Ont.) · 2025Article
- Article
- COVID-19 and Cancer Care: A Review and Practical Guide to Caring for Cancer Patients in the Era of COVID-19.Current oncology (Toronto, Ont.) · 2024Review
- As bleak as it sounds? Analysing trends in oncology clinical trial initiation in the UK from 2010 to 2022.BMJ oncology · 2024Article
- "Direct and indirect impacts of the COVID-19 pandemic on operational conduct of pediatric vaccine clinical trials".Human vaccines & immunotherapeutics · 2023Article
- Telehealth follow-up consultations for melanoma patients during the COVID-19 pandemic: Patient and clinician satisfaction.Cancer medicine · 2023Article
- Article
- Community Informed Recruitment: A Promising Method to Enhance Clinical Trial Participation.Journal of pain and symptom management · 2023Review
- Clinical research resource support for off-site research coordinators in intensive and specialty care units.Clinical and translational science · 2023Article
- Article
- Despite negative perceptions of clinical trial conduct during the coronavirus disease 2019 (COVID-19) pandemic, are decentralized clinical trial methods here to stay?Annals of translational medicine · 2023Article
- New reporting items and recommendations for randomized trials impacted by COVID-19 and force majeure events: a targeted approach.Annals of translational medicine · 2023Article
- Symptom clusters associated with complementary and alternative medicine use by cancer patients: A cross-sectional study.PloS one · 2023Article
- Impact of the COVID-19 pandemic on clinical trials: a cross-sectional questionnaire study in China.Annals of translational medicine · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
The coronavirus disease 2019 (COVID-19) pandemic has caused considerable global disruption to clinical practice. This article will review the impact that the pandemic has had on oncology clinical trials. It will assess the effect of the COVID-19 situation on the initial presentation and investigation of patients with suspected cancer. It will also review the impact of the pandemic on the subsequent management of cancer patients, and how clinical trial approval, recruitment, and conduct were affected during the pandemic. An intriguing aspect of the pandemic is that clinical trials investigating treatments for COVID-19 and vaccinations against the causative virus, SARS-CoV-2, have been approved and conducted at an unprecedented speed. In light of this, this review will also discuss the potential that this enhanced regulatory environment could have on the running of oncology clinical trials in the future.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.